The present assessment was meant to ascertain the plausible association of YKL-40, NLR, and PC with tumor grade, and evaluate their status as independent prognostic markers in terms of overall survival (OS) in therapy naïve glioma patients. This evidence concerns the gene CHI3L1 and central nervous system cancer.